On ECHEMI
Home > Drugs > Scalp damage
Scalp damage
The scalp is the surface barrier of the brain to defend against external violence. It has great elasticity and toughness, and has strong resistance to pressure and tension. Therefore, violence can be transmitted into the brain through the scalp and skull, causing damage to brain tissue, while the scalp is intact or slightly damaged. The structure of the scalp is significantly different from the skin of other parts of the body. The surface hair is dense and rich in blood supply. The subcutaneous tissue structure is dense. There are short fiber septa connecting the surface layer, subcutaneous tissue layer and galea aponeurotica layer together. The trinity is not easy to separate. It is rich in fat particles and has a certain protective effect. There is a loose connective tissue gap between the galea aponeurotica and the periosteum of the skull, which allows the scalp to slide, so it has the effect of buffering external violence. Scalp injury is the most common type of primary craniocerebral injury. It can range from slight abrasions to avulsions of the entire scalp. Its significance is that scalp injury helps to determine the location and severity of craniocerebral injury. Scalp injuries are often accompanied by varying degrees of skull and brain tissue damage, which can serve as a portal of entry for intracranial infection and cause secondary intracranial lesions. Therefore, reconstruction after scalp injury has received increasing attention.
  • Site of disease:

    Brain skin
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Trauma intracranial hemorrhage severe pain subcutaneous hematoma scalp avulsion
  • Concurrent disease:

    Scalp infection Subgaleal abscess
Related Drugs
Equine Tetanus Immunoglobulin (F(ab)2)
Indication: Used to prevent and treat tetanus. When tetanus or suspected symptoms have appeared, antitoxin treatment should be used in time while undergoing surgical treatment and other therapies. When there is a risk of tetanus infection from open wounds (especially those with deep wounds and serious contamination), prevention should be carried out in time. Anyone who has received tetanus toxoid immunization should receive another injection of toxoid to strengthen immunization after the injury, and there is no need to inject antitoxin; those who have not received toxoid immunization or have an unclear immunization history must be injected with antitoxin for prevention, but should also start toxin-like preventive injections at the same time to obtain lasting immunity.
Manufacturer:

Shanghai Serum Bio-Technology Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.